You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FOLFOXIRI

Showing 1 - 25 of 129
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Pisa (Bevacizumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Pisa, Italia, Italy
    Francesca Vannini
Jan 4, 2023

Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)

Not yet recruiting
  • Colorectal Cancer
  • Serplulimab + FOLFOXIRI
  • Radiation therapy
  • (no location specified)
Oct 24, 2023

Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin Trial in Beijing (Experimental: FOLFOXIRI and Lateral lymph node

Enrolling by invitation
  • Lymph Node Metastasis
  • +6 more
  • Experimental: FOLFOXIRI and Lateral lymph node dissection
  • Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
Sep 15, 2023

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

Cancer of Rectum Trial in New Brunswick (combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI

Recruiting
  • Cancer of Rectum
  • combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil)
  • Lakewood, New Jersey
  • +4 more
Nov 2, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus

Not yet recruiting
  • Stage II Colon Cancer
  • Stage III Colon Cancer
  • 5-Fluorouracil continuous infusion FOLFOXIRI schedule
  • +8 more
  • (no location specified)
Aug 3, 2022

Rectal Cancer Trial in Shanghai (FOLFOXIRI, CapeOX)

Recruiting
  • Rectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Feb 16, 2022

Colorectal Cancer Trial in Vejle (Irinotecan 165 mg/m2 iv, Oxaliplatin 85 mg/m2 iv, Calcium folinate 200 mg/m2 iv)

Active, not recruiting
  • Colorectal Cancer
  • Irinotecan 165 mg/m2 iv
  • +5 more
  • Vejle, Denmark
    Department of Oncology, Vejle Hospital
Aug 16, 2022

Metastatic Colorectal Cancer Trial in Cairo (FOLFOXIRI Protocol)

Completed
  • Metastatic Colorectal Cancer
  • FOLFOXIRI Protocol
  • Cairo, El Manial, Egypt
    Kasr El AiniH
Mar 30, 2022

Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan,

Recruiting
  • Liver Metastasis Colon Cancer
  • Synchronous Neoplasm
  • Neo-adjuvant Chemotherapy FOLFOXIRI Regimen
  • synchronous resection surgery
  • Ho Chi Minh City, Vietnam
    Cho Ray hospital- 201 B Nguyen Chi Thanh, District 5
May 5, 2022

Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Munich, Germany
    Klinikum der Universitaet Muenchen
Dec 2, 2021

Rectal Cancer Trial in Stanford (FOLFOXIRI, FOLFOX regimen, XELOX)

Recruiting
  • Rectal Cancer
  • FOLFOXIRI
  • +3 more
  • Stanford, California
    Stanford University
Jan 13, 2022

Colon Cancer Stage III Trial in Daejeon (FOLFOXIRI, mFOLFOX 6)

Recruiting
  • Colon Cancer Stage III
  • FOLFOXIRI
  • mFOLFOX 6
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Dec 17, 2021

Colon Cancer Stage II, Colon Cancer Stage III Trial in Guangzhou (neoadjuvant chemoI, Colectomy, adjuvant chemo)

Recruiting
  • Colon Cancer Stage II
  • Colon Cancer Stage III
  • neoadjuvant chemotherapyI
  • +2 more
  • Guangzhou, Guangdong, China
    651 Dongfeng Road East
Jan 14, 2022

Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)

Not yet recruiting
  • Colorectal Cancer
  • FOLFOX , FOLFIRI or FOLFOXIRI regimens
  • FOLFOX regimen
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 26, 2023

High-risk Locally Advanced Colorectal Cancer, Neoadjuvant Chemo, FOLFOXIRI Regimen Trial in Chengdu (Oxaliplatin, Irinotecan,

Recruiting
  • High-risk Locally Advanced Colorectal Cancer
  • +2 more
  • Chengdu, Sichuan, China
    Sichuan University West China Hospital
Aug 18, 2021

Liver Metastasis Colon Cancer Trial in Shanghai (Cetuximab, Bevacizumab, FOLFOXIRI)

Recruiting
  • Liver Metastasis Colon Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Cance
Apr 5, 2021

Colorectal Tumors, Drug Therapy Trial in Shenyang (FOLFOXIRI)

Recruiting
  • Colorectal Neoplasms
  • Drug Therapy
  • FOLFOXIRI
  • Shenyang, Liaoning, China
    Liaoning cancer hospital
Apr 13, 2021

Rectal Cancer Trial in Guangzhou (FOLFOXIRI)

Completed
  • Rectal Cancer
  • FOLFOXIRI
  • Guangzhou, Guangdong, China
    Gastrointestinal Hospital, Sun Yatsen University
Apr 10, 2021

Colonic Tumors, Drug Therapy Trial in Shenyang (FOLFOXIRI)

Recruiting
  • Colonic Neoplasms
  • Drug Therapy
  • FOLFOXIRI
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital
Apr 14, 2021

Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Jun 17, 2022

Rectal Tumors, Drug Therapy, Radiation Trial in Shenyang (FOLFOXIRI, Short-Course Radiation Therapy(5Gy*5), XELOX)

Recruiting
  • Rectal Neoplasms
  • +2 more
  • FOLFOXIRI
  • +2 more
  • Shenyang, China
    China Medical University
Apr 13, 2021

Locally Advanced Rectal Cancer Trial in Pisa (drug, radiation, procedure)

Recruiting
  • Locally Advanced Rectal Cancer
  • Pisa, Italy
    U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Univ
Mar 9, 2022